| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |